Evidence map›Paper›PMID 40070619›Full record

ArticleCureus2025

A Severe Manic Episode Induced by Corticosteroid Treatment in a Patient With Subthreshold Bipolar Disorder.

Tomonori Hara, Yusuke Kaichi, Keisuke Imai, Shiho Hattori

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tomonori HaraPsychiatry, Hatsuishi Hospital, Kashiwa, JPN.
Yusuke KaichiPsychiatry, Hatsuishi Hospital, Kashiwa, JPN.
Keisuke ImaiPsychiatry, Hatsuishi Hospital, Kashiwa, JPN.
Shiho HattoriPsychiatry, Hatsuishi Hospital, Kashiwa, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosteroid treatment sometimes causes psychiatric side effects such as mania, depression, and psychosis. It is believed that exogenous corticosteroids lead to dysregulation of corticosteroid signaling and neurotransmitters in a dose-dependent manner. Therefore, the administration of corticosteroids is at risk of worsening bipolar disorder. Here, we present a case of a female patient with subthreshold untreated bipolar disorder who experienced a severe manic episode after corticosteroid treatment. She had a history of childhood asthma but no remarkable psychiatric medical history except for subthreshold mood swings. At age 30, she had her first asthma attack in over 10 years, for which she received intravenous corticosteroids. A week later she was admitted to a psychiatric hospital due to severe manic symptoms. She was diagnosed with corticosteroid-induced mania and was treated with olanzapine. After remission, olanzapine was gradually reduced. However, she experienced a recurrent manic episode. Her diagnosis was updated to bipolar disorder, and she has resumed medication. This case highlights the risk of corticosteroids worsening bipolar disorder and the need to carefully assess previous psychiatric symptoms before using corticosteroids.

Indexed as

aripiprazoleasthmabipolar disordercoritosteroid-induced maniaolanzapinesteroid-induced mania

Identifiers

PMID40070619
PMCPMC11895727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.